Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
CORVEX INC (MOVE)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-11-05
$5.26-17.81%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for MOVE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Grow AI platform revenue and contracted annualized recurring revenue | This growth supports their goal of $22 million in contracted annualized recurring revenue. | Intact | contracted annualized recurring revenue falls below $22 million by year-end 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business, not an established compounder, with loss-making earnings and high risk. The long-term thesis is in a watch state: early AI revenue and contracted demand are encouraging, but recent performance is weak and management execution is volatile.
MOVE is described as cheap versus peers, and its valuation measure fell from 50.9 to 20.3. That suggests expectations have been reduced, but the evidence does not show exactly what the market assumes; losses and high risk still make the valuation case uncertain.
Near term, results remain weak relative to the industry cohort, and smaller-company scale plus recent peer misses leave some risk around execution. AI platform revenue rose from $0.51 million in the first quarter to $3.8 million in the second, while contracted annualized recurring revenue on live compute was about $22 million as of August 14. Management has funding for a planned capacity increase, but delivery and guidance remain important tests.
The multi-year case depends on converting contracted AI demand into sustained revenue and expanding critical IT power capacity from about 1.5 MW to 8 MW by year-end 2026. A guidance cut would be a meaningful negative; Fed rate cuts or steadier results and guidance from major technology peers could support the sector backdrop.
Over the next one to three years, MOVE has a promising but unproven growth opportunity alongside losses, weak recent performance, and high execution risk. The thesis hinges on revenue conversion, capacity expansion, and avoiding a guidance cut. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 1 supplied quarters. Management reported: “Corvex defines this operating metric as the annualized value of fixed contractual fees on capacity that has been delivered, accepted by the customer and is generating revenue as of the stated date.” ““We recognized $3.8 million of revenue in the quarter, while contracted annualized recurring revenue on live compute is approximately $22 million as of today.”
Expand critical IT power capacity with data center growth | They plan to increase IT power capacity from 1.5 MW to 8 MW by year-end 2026. | Intact | capacity expansion fails to reach 8 MW by year-end 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “Together, the deployments are expected to increase Corvex’s critical IT power capacity from approximately 1.5 MW today to approximately 8 MW by the end of 2026.” “The deployments are expected to bring approximately 2,000 latest-generation GPUs online at the Midwest site, with approximately 1,000 additional GPUs at the Mid-Atlantic site.” Delivery assessment Nov 5, 2026 |
Strengthen leadership and governance post-merger | A supporting condition in CORVEX INC's published investment case. The stated target is stable leadership team in place. | Under Pressure | leadership changes lead to instability or governance issues within the next year | Qualitative: Active governance challenge (Corvex board bid) vs stable leadership target Corvex called for a board seat amid strategic challenges; Whitbread urged shareholders to reject the bid, indicating governance tension. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.08 → $-0.08 · observed estimates
$0.20B → $0.20B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-17 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-18 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-19 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-20 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-21 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-22 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-23 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-24 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-25 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-26 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-27 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-28 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-29 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-09-30 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-01 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-02 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-03 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-04 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-05 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-06 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-07 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-08 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-09 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-10 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-11 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-12 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-13 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-14 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-15 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-16 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-17 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-18 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-19 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-20 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-21 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-22 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-23 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-24 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-25 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-26 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-27 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-28 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-29 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-30 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-10-31 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-11-01 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-11-02 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-11-03 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-11-04 | $-0.08 | $199,744,000 | 1 / 1 |
| 2026-11-05 | $-0.08 | $199,744,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.